Heninger Garrison Davis is at the forefront of mass tort litigation, standing up for individuals who have suffered due to defective medical devices. If you or a loved one experienced complications from a BioZorb implant, you may be eligible to file a lawsuit against Hologic Inc. for failing to warn about the risks.
What Is the BioZorb Lawsuit About?
BioZorb Markers were introduced as an innovative solution in breast cancer treatment, designed to assist with radiation targeting and post-surgical imaging. Manufactured by Hologic Inc., the device was supposed to dissolve over time, leaving behind small titanium clips to help locate the site of a removed tumor.
However, hundreds of patients have reported that their BioZorb implant did not resorb as intended, leading to severe complications, including device migration and even breaking through the skin. Since 2015, nearly 400 complaints have been filed.
In October 2024, Hologic voluntarily recalled all unused BioZorb Marker and BioZorb LP Marker devices. The FDA followed suit, classifying the recall as Class 1, the highest level of safety concern, due to the risks discussed below.
The FDA advises that patients who already have a BioZorb implant should monitor for complications and consult a healthcare provider if issues arise. If you’ve suffered complications, you may have a legal claim against Hologic for failing to warn patients adequately about the risks.